<DOC>
	<DOCNO>NCT00717431</DOCNO>
	<brief_summary>The primary goal determine whether hippocampal electrical stimulation ( HS ) safe effective simply implant electrode hippocampus without electrical stimulation ( HI ) , patient mesial temporal lobe epilepsy ( MTLE ) . This assessed rate complex partial seizure per person-month 6 month follow-up HS vs. HI . There two treatment arm : 1 ) Hippocampal Electrode Implantation Stimulation ( HS ) . 2 ) Hippocampal Electrode Implantation without stimulation ( HI ) . The investigator expect demonstrate HS safe superior HI control seizure patient MTLE .</brief_summary>
	<brief_title>A Multicenter Study Hippocampal Electrical Stimulation ( HS , Mesial Temporal Lobe Epilepsy</brief_title>
	<detailed_description>This multicentre , parallel-group , double blind randomize control trial involve patient MTLE may candidate resective surgery whose memory function precludes resective surgery . Eligible patient randomize 2:1 ratio hippocampal electrode implantation stimulation ( HS ) , hippocampal electrode implantation without stimulation ( HI ) . Patients follow seven month randomization . One month devote adjustment intervention , 6 month follow-up outcome assessment . At end seven month , patient offer option HS , electrode removal , surgical therapy medical therapy , base best evidence patient preference . Primary Question : In patient MTLE , 6-month period : Is continuous HS plus medical therapy ( MT ) efficacious hippocampal implantation ( HI ) plus MT reduce seizure frequency ? Secondary Questions : In patient MTLE , 6-month period : 1 . Is HS safe ? 2 . What effect HS cognition , mood , quality life ? 3 . What effect HS psychiatric morbidity ? 4 . Is efficacy HS associate presence , location amount interictal hippocampal spike depth electrode recording ?</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsy , Temporal Lobe</mesh_term>
	<criteria>Unilateral Bilateral Mesial Temporal lobe Epilepsy . Age ≥ 18 year . Global IQ ≥70 . Failure ≥ 2 AEDs approve treatment partial seizure , use alone combination recommend dosage . Average ≥ 3 seizuredays per month prior 6 month disable seizure occur . Disabling seizure define complex partial seizure without secondary generalization , simple partial seizure noticeable others interfere function . Ability complete selfadministered questionnaire . Availability reliable collateral historian witness . Patient preference nonresective surgery , candidate mesial temporal resection . Give write informed consent . Extratemporal multifocal epilepsy . MRI evidence potentially epileptogenic lesion outside mesial temporal region . Lesions preclude electrode implantation ( eg , vascular malformation , vascular tumor ) . Severe hippocampal sclerosis surgeon 's opinion precludes accurate electrode placement . Brain lesion demand prompt surgical therapy ( eg , malignant tumor , vascular malformation ) . Progressive neurological disorder ( eg , malignant tumor , dementia , degenerative disorder ) . Medical psychiatric condition preclude surgery interfere adherence treatment followup . Planned pregnancy study . Women childbearing age require negative pregnancy test adequate contraception method . Ongoing plan participation study new epilepsy therapy . Contraindication stereotactic surgery , e.g . bleed diathesis , anticoagulant , treatment valproate time surgery ( risk bleeding ) . Any condition would make participation trial detrimental patient 's health .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Seizures</keyword>
	<keyword>Epilepsy</keyword>
</DOC>